FARMINGTON, Conn., Dec. 6, 2012 /PRNewswire-iReach/ -- The incidence
of cancer is rising worldwide with over 13 million cases recorded
in the year 2008 alone. Worldwide, the rate of growth of cancer is
expected to rise further and reach 17 million by 2030. Market
growth in the US is driven by an increasing number of cancer cases,
a favorable reimbursement policy pertaining to radiation therapy
for cancer, as well as rapid acceptance of advanced and novel
treatment procedures. In the US, about half the number of cancer
patients undergo radiation therapy, a percentage that is expected
to rise further. Highly accurate and targeted radiation therapy has
the potential to replace surgery, and as a result increase its
adoption. Much of the future growth of radiotherapy depends upon
the availability of more effective technologies.
(Photo: http://photos.prnewswire.com/prnh/20121206/CG25662)
Global Information Inc (GII) presents two significant market
research reports covering the global radiation therapy and nuclear
medicine reports from our premium research partner Global Industry
Analysts, Inc.
Radiation Therapy Equipment
The global market for radiation therapy equipment is projected
to reach $6.8 billion by 2018. The global Radiation Therapy
Equipment market is dominated by a handful of global players, owing
to the high level of complexity in the systems. As such, the global
players dominate sales in all the regional markets. Moreover, all
the players in the global market are based in North America or Europe. Major players in the global
marketplace include Accuray Incorporated, Elekta AB, Nordion, Inc.,
Philips Healthcare, Siemens Healthcare, and Varian Medical Systems
Inc.
Emerging markets such as Asia-Pacific, Eastern Europe, and Latin America hold vast opportunities for
market participants. Growth in these markets is expected to arise
from increased replacements and emergence of additional
applications for the equipment, while the market in developed
countries is relatively mature. Growth in such markets would be
driven by accurate conformal technologies and to a certain extent
from replacement demand. Over the past few years, population of
cancer patients in developed countries has reduced significantly,
thereby effectively slowing annual growth. Early diagnosis,
improved treatment, and advanced technology have increased the
survival rate of cancer patients. However, the radiation equipment
market faces challenges in the form of pressures due to changing
reimbursements, and volatility related to sales of capital
equipment.
Linear Accelerators represents the largest Radiation Therapy
Equipment segment. On the other hand, Treatment Planning Systems
presents the highest growth opportunities. Image-guided radiation
therapy is a major trend in the radiotherapy market as the
technology enables identification of the precise position of a
tumor prior to radiation delivery, and minimizes risk of damaging
healthy tissue during treatment. Demand for IGRT machines is high
as oncologists are seeking image-guidance functionality. Another
trend in the radiation therapy market is advanced motion detection,
which detects any shift in position of a tumor located near moving
organs, such as the lungs and heart.
An Executive Summary for this report and free sample pages from
the full document are available at
http://www.giiresearch.com/report/go138753-radiation-thera-equip.html
Nuclear Medicine
The global market for nuclear medicine is forecast to reach
$2.46 billion by the year 2018.
Nuclear medicine encompasses therapeutic and diagnostic
procedures, which are economical, safe and painless techniques.
Following years of strong growth, the global nuclear medicine
market entered into a tumultuous phase beginning 2008. The global
economic downturn on one side and changes in reimbursement and
insurance requirements in developed markets such as the US on the
other, have resulted in market declines that lasted until 2010.
Other factors such as saturated Western markets, restrictions
imposed by the Governments in certain high potential countries such
as China, and low rates of
reimbursement have weighed down market growth and resulted in a
decline in the sales of imaging equipment.
The nuclear medicine market is fairly concentrated. A handful of
the most influential medical device companies control a majority
share in the worldwide nuclear medicine market. These companies
operate large sales force, and have significant installed base and
strong research and development activities. Key players profiled in
the report include Digirad Corporation, GE Healthcare Plc, Philips
Healthcare Inc., Positron Corporation, Siemens, and Toshiba Medical
Systems Corporation, among others.
An Executive Summary for this report and free sample pages from
the full document are available at
http://www.giiresearch.com/report/go138655-nuclear-medicine.html
About Global Information Inc. Global Information (GII)
(http://www.giiresearch.com) is an information service company
partnering with over 300 research companies around the world.
Global Information has been in the business of distributing
technical and market research for more than 25 years. Expanded from
its original headquarters in Japan, Global Information now has offices in
Korea, Taiwan, Singapore, Europe and the
United States.
Media Contact: Yuko Ueki Global Information, Inc.,
860-674-8796, US-marketing@gii.co.jp
News distributed by PR Newswire iReach:
https://ireach.prnewswire.com
SOURCE Global Information, Inc.